Company insiders
Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source | Follow |
|---|---|---|---|---|---|---|---|
| Dumont Lisa M VP, Controller & CAO · CABOT CORP | CBT CABOT CORP | Other transactionFiling detailsSEC transaction code F Common Stock · Direct ownership · Reported balance after transaction: 13111.62 · Securities delivered or withheld for tax or exercise payment | 2026-11-18 | 2026-11-20 | 335 shares/units | SEC 4 | Follow |
| Dumont Lisa M VP, Controller & CAO · CABOT CORP | CBT CABOT CORP | Equity grant or awardFiling detailsSEC transaction code A Common Stock · Direct ownership · Reported balance after transaction: 13446.62 · Consists of performance based units earned on the basis of the Corporation's performance in fiscal year 2026, of which 406 remain subject to time-based vesting. | 2026-11-18 | 2026-11-20 | 592 shares/units | SEC 4 | Follow |
| LEWIS HAROLD G Director · UPBOUND GROUP, INC. | UPBD UPBOUND GROUP, INC. | BuyFiling detailsSEC transaction code P COMMON STOCK · Direct ownership · Reported balance after transaction: 15300 · SEC code covers open-market or private transactions · The price in Column 4 is a weighted average price of $26.05. These shares were purchased in multiple transactions at prices ranging from $25.99 to $26.13, inclusive. The reporting person undertakes to provide to Upbound Group, Inc., any security holder of Upbound Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the foregoing range. · Power of Attorney (Exhibit) | 2026-11-18 | 2026-11-20 | ≈ $398,565.00 15,300 shares/units | SEC 4 | Follow |
| McLaughlin Erica President and CEO · CABOT CORP | CBT CABOT CORP | Other transactionFiling detailsSEC transaction code F Common Stock · Direct ownership · Reported balance after transaction: 97317 · Securities delivered or withheld for tax or exercise payment | 2026-11-18 | 2026-11-20 | 3,961 shares/units | SEC 4 | Follow |
| McLaughlin Erica President and CEO · CABOT CORP | CBT CABOT CORP | Equity grant or awardFiling detailsSEC transaction code A Common Stock · Direct ownership · Reported balance after transaction: 101278 · Consists of performance based units earned on the basis of the Corporation's performance in fiscal year 2026, of which 3,640 remain subject to time-based vesting. | 2026-11-18 | 2026-11-20 | 5,054 shares/units | SEC 4 | Follow |
| Hyman Jonathan Chief Technology Officer · Braze, Inc. | BRZE Braze, Inc. | SellFiling detailsSEC transaction code S Class A Common Stock · Direct ownership · Reported balance after transaction: 802963 · SEC code covers open-market or private transactions · Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on April 14, 2026. · The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.22 to $46.56 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. · Of the reported shares, 158,649 shares are represented by restricted stock units and performance-based restricted stock units. | 2026-11-19 | 2026-11-20 | ≈ $429,431.07 9,249 shares/units | SEC 4 | Follow |
| FURST JACK D Director · Drilling Tools International Corp | DTI Drilling Tools International Corp | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 260948 · SEC code covers open-market or private transactions | 2026-11-19 | 2026-11-20 | ≈ $83,749.05 50,757 shares/units | SEC 4 | Follow |
| FURST JACK D Director · Drilling Tools International Corp | DTI Drilling Tools International Corp | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 210191 · SEC code covers open-market or private transactions | 2026-11-18 | 2026-11-20 | ≈ $81,250.95 49,243 shares/units | SEC 4 | Follow |
| Shulman Joseph Chief Technical Officer · RHYTHM PHARMACEUTICALS, INC. | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise or conversionFiling detailsSEC transaction code M Stock Options (Right to Buy) · Derivative security · Direct ownership · Reported balance after transaction: 28126 · The Exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. · The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. | 2026-11-18 | 2026-11-20 | 9,374 shares/units | SEC 4 | Follow |
| Shulman Joseph Chief Technical Officer · RHYTHM PHARMACEUTICALS, INC. | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise or conversionFiling detailsSEC transaction code M Stock Options (Right to Buy) · Derivative security · Direct ownership · Reported balance after transaction: 25306 · The Exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. · The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. | 2026-11-18 | 2026-11-20 | 24,944 shares/units | SEC 4 | Follow |
| Shulman Joseph Chief Technical Officer · RHYTHM PHARMACEUTICALS, INC. | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise or conversionFiling detailsSEC transaction code M Stock Options (Right to Buy) · Derivative security · Direct ownership · Reported balance after transaction: 8375 · The Exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. · The stock options were granted on February 1, 2023. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. | 2026-11-18 | 2026-11-20 | 4,188 shares/units | SEC 4 | Follow |
| Shulman Joseph Chief Technical Officer · RHYTHM PHARMACEUTICALS, INC. | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise or conversionFiling detailsSEC transaction code M Stock Options (Right to Buy) · Derivative security · Direct ownership · Reported balance after transaction: 3984 · The Exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. · The stock options were granted on February 9, 2022. The options vested and became exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. | 2026-11-18 | 2026-11-20 | 1,961 shares/units | SEC 4 | Follow |
| Shulman Joseph Chief Technical Officer · RHYTHM PHARMACEUTICALS, INC. | RYTM RHYTHM PHARMACEUTICALS, INC. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 10461 · SEC code covers open-market or private transactions · The Exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. · The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $119.75 to $120.36 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | 2026-11-18 | 2026-11-20 | ≈ $5,506,152.91 45,921 shares/units | SEC 4 | Follow |
| Shulman Joseph Chief Technical Officer · RHYTHM PHARMACEUTICALS, INC. | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise or conversionFiling detailsSEC transaction code M Common Stock · Direct ownership · Reported balance after transaction: 56382 · The Exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. | 2026-11-18 | 2026-11-20 | 9,374 shares/units | SEC 4 | Follow |
| Shulman Joseph Chief Technical Officer · RHYTHM PHARMACEUTICALS, INC. | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise or conversionFiling detailsSEC transaction code M Common Stock · Direct ownership · Reported balance after transaction: 47008 · The Exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. | 2026-11-18 | 2026-11-20 | 24,944 shares/units | SEC 4 | Follow |
| Shulman Joseph Chief Technical Officer · RHYTHM PHARMACEUTICALS, INC. | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise or conversionFiling detailsSEC transaction code M Common Stock · Direct ownership · Reported balance after transaction: 22064 · The Exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. | 2026-11-18 | 2026-11-20 | 4,188 shares/units | SEC 4 | Follow |
| Shulman Joseph Chief Technical Officer · RHYTHM PHARMACEUTICALS, INC. | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise or conversionFiling detailsSEC transaction code M Common Stock · Direct ownership · Reported balance after transaction: 17876 · The Exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. | 2026-11-18 | 2026-11-20 | 1,961 shares/units | SEC 4 | Follow |
| TOCIO MARY ANN Director · BRIGHT HORIZONS FAMILY SOLUTIONS INC. | BFAM BRIGHT HORIZONS FAMILY SOLUTIONS INC. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 8571.00 · SEC code covers open-market or private transactions | 2026-11-20 | 2026-11-20 | ≈ $287,319.59 5,758 shares/units | SEC 4 | Follow |
| Malcolm Gregory EVP and Controller · COLGATE PALMOLIVE CO | CL COLGATE PALMOLIVE CO | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 8542.0000 · SEC code covers open-market or private transactions · Reflects seven shares purchased by the reporting persons broker in October 2022 without the reporting persons prior knowledge and discovered in November 2026. · Represents holdings as of the date of the reported transaction. As of the date of this filing, the reporting person directly owns 10,079 shares. | 2022-10-04 | 2026-11-20 | ≈ $502.53 7 shares/units | SEC 4 | Follow |
| Sayward Shelley E. Executive VP & GENERAL COUNSEL · CASELLA WASTE SYSTEMS INC | CWST CASELLA WASTE SYSTEMS INC | SellFiling detailsSEC transaction code S Class A Common Stock · Direct ownership · Reported balance after transaction: 21369 · SEC code covers open-market or private transactions | 2026-11-20 | 2026-11-20 | ≈ $700,000.00 7,000 shares/units | SEC 4 | Follow |
| ERICKSON THOMAS W Director · 3D SYSTEMS CORP | DDD 3D SYSTEMS CORP | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 515178 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.35 to $1.37, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | 2026-11-18 | 2026-11-20 | ≈ $163,200.00 120,000 shares/units | SEC 4 | Follow |
| Paradis Paul Director & President · Director · Sezzle Inc. | SEZL Sezzle Inc. | Exercise or conversionFiling detailsSEC transaction code M Stock Options · Derivative security · Direct ownership · Reported balance after transaction: 0 | 2026-11-18 | 2026-11-20 | 78,954 shares/units | SEC 4 | Follow |
| Paradis Paul Director & President · Director · Sezzle Inc. | SEZL Sezzle Inc. | Exercise or conversionFiling detailsSEC transaction code M Common Stock, par value $0.00001 per share · Direct ownership · Reported balance after transaction: 461954 | 2026-11-18 | 2026-11-20 | 78,954 shares/units | SEC 4 | Follow |
| Burt Carol Director · RESMED INC | RMD RESMED INC | Equity grant or awardFiling detailsSEC transaction code A ResMed Common Stock · Direct ownership · Reported balance after transaction: 3265 · Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2027, or the annual meeting of stockholders in the year following the grant date. | 2026-11-19 | 2026-11-20 | 1,109 shares/units | SEC 4 | Follow |
Joint filing · 4 reporting ownersPlayboy, Inc. | PLBY Playboy, Inc. | BuyFiling detailsSEC transaction code P Common Stock · Indirect ownership · See footnotes · Reported balance after transaction: 20572554 · SEC code covers open-market or private transactions · The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.17 inclusive. The Reporting Persons undertake to provide the staff of the SEC, the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within such range. · Held by The Million S.a. r.l. ("The Million"). The Million is a wholly owned subsidiary of Byborg Enterprises S.A. ("Byborg"). Byborg is a subsidiary of Docler Holding S.a r.l. ("Docler"). Gyorgy Gattyan is the Class A Manager and sole equity owner of Docler and serves on the board of directors of the Issuer. · Each of the Reporting Persons and Mr. Gattyan disclaims beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that any Reporting Person or Mr. Gattyan is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. | 2026-11-20 | 2026-11-20 | ≈ $221,330.80 191,000 shares/units | SEC 4 | From owner profile |
Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.